Folic Acid Supplementation for Stroke Prevention in Patients With Cardiovascular Disease

@article{Tian2017FolicAS,
  title={Folic Acid Supplementation for Stroke Prevention in Patients With Cardiovascular Disease},
  author={T. Tian and Kunqi Yang and J. Cui and Lanlan Zhou and Xian-liang Zhou},
  journal={The American Journal of the Medical Sciences},
  year={2017},
  volume={354},
  pages={379–387}
}
Background: Controversy remains regarding the efficacy of folic acid supplementation in reducing the risk of stroke. This study aimed to evaluate the effect of folic acid supplementation on stroke prevention in patients with cardiovascular disease (CVD). Materials and Methods: We searched the PubMed, EMBASE and Cochrane Library databases through October 2016 to identify randomized clinical trials of folic acid supplementation to prevent stroke in patients with CVD. Relative risks (RRs) with 95… Expand
B vitamins for stroke prevention
  • G. Hankey
  • Medicine
  • Stroke and Vascular Neurology
  • 2018
TLDR
Evidence from observational genetic epidemiological studies, randomised controlled clinical trials, and evidence from established policies of population folate supplementation is concordant in suggesting an absence of benefit from lowering of homocysteine with folic acid for prevention of stroke. Expand
Effect of Vitamin B6, B9, and B12 Supplementation on Homocysteine Level and Cardiovascular Outcomes in Stroke Patients: A Meta-Analysis of Randomized Controlled Trials
TLDR
A meta-analysis demonstrated up-to-date evidence on the beneficial effect of vitamin B supplementations in reducing homocysteine and preventing the combined risk of stroke, myocardial infarction, and vascular death among stroke patients. Expand
The current status of homocysteine as a risk factor for cardiovascular disease: a mini review
TLDR
A focused Medline search of the English language literature was conducted between 2010 and 2017 using the terms, homocysteine, risk factor, atherosclerosis, cardiovascular disease, stroke, treatment, and 38 papers with pertinent information were selected and there is a controversy regarding the significance of homocy steine as a risk factor for CVD and stroke. Expand
Benefits and risks of the treatment with fibrates––a comprehensive summary
TLDR
Fibrates are performing well as drugs that reduce residual risk in patients with atherogenic dyslipidemia and hypertriglyceridemia, and the adverse events rate is not negligible, but definitely manageable by selection of proper target population and supervision of treated patients. Expand
Linking homocysteine, B vitamins, and choline to ischemic stroke risk
TLDR
The aim of this chapter is to discuss how homocysteine, folates, and choline are implicated in the onset of ischemic stroke. Expand
Dietary Intake of Homocysteine Metabolism-Related B-Vitamins and the Risk of Stroke: A Dose-Response Meta-Analysis of Prospective Studies
TLDR
It is found that dietary intake of vitamin B-6 and folate were associated with a reduced risk of stroke, and this inverse association remained significant in studies with >10 y of follow-up periods and among participants without a pre-existing stroke event. Expand
Overview of Meta-Analyses: The Impact of Dietary Lifestyle on Stroke Risk
TLDR
An overview of meta-analyses that have investigated the impact of different foods and/or drinks in relationship with the risk of stroke events shows that all primary studies came from countries with high income levels. Expand
The importance of homocysteine in the development of cardiovascular complications in patients with rheumatoid arthritis
Rheumatoid arthritis (RA) not only leads to disability due to joint changes, but also significantly shortens the life expectancy of patients, mainly due to more frequent occurrence of heart attacksExpand
One-carbon metabolism supplementation improves outcome after stroke in aged male MTHFR-deficient mice
TLDR
A critical role for one‑carbon supplementation, with 5-methylTHF, vitamin B12, and choline, in supporting improvement after ischemic stroke damage is revealed. Expand
Overview of Meta-Analyses: The Impact of Lifestyle on Stroke Risk
TLDR
An overview of meta-analyses that have investigated the impact of different foods and / or drinks in relationship with the risk of stroke events (ischemic/ hemorrhagic) shows that all primary studies came from countries with high income level. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 52 REFERENCES
Efficacy of folic acid supplementation in stroke prevention: a meta-analysis
TLDR
It is indicated that folic acid supplementation can effectively reduce the risk of stroke in primary prevention and should be considered as a standalone treatment for stroke prevention. Expand
EFFICACY OF FOLIC ACID SUPPLEMENTATION IN STROKE PREVENTION: NEW INSIGHT FROM A META-ANALYSIS
TLDR
Folic acid supplementation is effective in stroke prevention in populations with no or partial folic acid fortification, and a greater beneficial effect was observed among trials with a lower percent use of statins. Expand
Efficacy of Homocysteine-Lowering Therapy With Folic Acid in Stroke Prevention: A Meta-Analysis
TLDR
Folic acid supplementation did not demonstrate a major effect in averting stroke, however, potential mild benefits in primary stroke prevention, especially when folate is combined with B vitamins and in male patients, merit further investigation. Expand
Effect of B-vitamin Supplementation on Stroke: a Meta-Analysis of Randomized Controlled Trials
TLDR
This study indicates that B-vitamin supplementation is not associated with a lower risk of stroke based on relative and absolute measures of association. Expand
Vitamin B supplementation, homocysteine levels, and the risk of cerebrovascular disease
TLDR
B vitamin supplementation for homocysteine reduction significantly reduced stroke events, especially in subjects with certain characteristics who received appropriate intervention measures. Expand
Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial.
TLDR
In this medium-size pilot study, folic acid did not demonstrate any beneficial additive effects on cardiovascular mortality or morbidity in post-MI patients with hypercholesterolemia who were treated with statin therapy. Expand
Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial.
TLDR
Among adults with hypertension in China without a history of stroke or MI, the combined use of enalapril and folic acid, compared with en alapril alone, significantly reduced the risk of first stroke. Expand
Homocysteine lowering with folic acid and B vitamins in vascular disease.
TLDR
Supplements combining folic acid and vitamins B6 and B12 did not reduce the risk of major cardiovascular events in patients with vascular disease. Expand
Secondary prevention with folic acid: results of the Goes extension study
TLDR
The results of an open label intervention study with folic acid in a population with stable coronary artery disease while taking stable statin treatment did not appear to attenuate the risk for recurrent events and longer follow up observations are necessary before definite conclusions can be made. Expand
Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial.
TLDR
After 7.3 years of treatment and follow-up, a combination pill of folic acid, vitamin B6, and vitamin B12 did not reduce a combined end point of total cardiovascular events among high-risk women, despite significant homocysteine lowering. Expand
...
1
2
3
4
5
...